Concepedia

Publication | Closed Access

A phase 2 multicenter study of tivantinib (ARQ 197) monotherapy in patients with relapsed or refractory germ cell tumors

DOI

53

Citations

18

References

2013

Year

Darren R. Feldman, Lawrence H. Einhorn, David I. Quinn, Yohann Loriot, Johnathan Joffe, David J. Vaughn, Aude Fléchon, Julio Hajdenberg, Abdel‐Baset Halim, Hamim Zahir,
Investigational New Drugs

References

YearCitations

Page 1